
GC19178
GSK189254A
Also known as 6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide
GSK189254A (GSK189254) is a novel, potent and selective histamine H3 receptor antagonist with pKi values of 9·59-9·90 and 8·51-9·17 for human and rat H3, respectively
ChemicalCAS720690-73-3MW351.44FormulaC21H25N3O2
- CAS number
- 720690-73-3
- Molecular weight
- 351.44
- Formula
- C21H25N3O2
- Solubility
- DMSO : 6 mg/mL (17·07 mM)
- InChIKey
- WROHEWWOCPRMIA-UHFFFAOYSA-N
- Catalogue number
- GC19178
- Brand
- GLPBIO
Computed properties PubChem CID 9798547 · XLogP 3.2 · TPSA 54.5 Ų · H-bond donors 1
- XLogP
- 3.2
- TPSA
- 54.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 26
SMILES CNC(=O)C1=CN=C(C=C1)OC2=CC3=C(CCN(CC3)C4CCC4)C=C2
Computed descriptors from PubChem (CID 9798547), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il